4//SEC Filing
Eizen Joshua M 4
Accession 0000950170-25-003152
CIK 0001880438other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 7:57 PM ET
Size
5.2 KB
Accession
0000950170-25-003152
Insider Transaction Report
Form 4
Eizen Joshua M
See Remarks
Transactions
- Sale
Common Stock
2025-01-03$1.34/sh−9,663$12,958→ 116,672 total
Footnotes (2)
- [F1]Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on January 1, 2025.
- [F2]Includes (a) 31,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024 (b) 22,500 RSUs which vest as follows: 1/3rd of the RSUs vest annually over three years from January 1, 2025 and (c) 45,000 RSUs which vest as follows: 2/3rd of the RSU vest on January 1, 2026 and 1/3rd of the RSUs vest on July 1, 2026, subject to the Reporting Person's continuous service as of such date.
Documents
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeother
Related Parties
1- filerCIK 0001949621
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 7:57 PM ET
- Size
- 5.2 KB